Table 2.
Clinical outcomes of 11 successful cases.
| n = 11 | |
|---|---|
| Puncture site, n (%) | |
| B2 | 5 (45.5) |
| B3 | 6 (54.5) |
| Puncture bile duct diameter, mm, median (range) | 4.4 (3.1–5.7) |
| Combined with ultrasound-guided antegrade procedure, n (%) | 2 (18.2) |
| Clinical success, n (%) | 11 (100) |
| Procedure time, min, median (range) | 35 (15–93) |
| Type of stent placed for hepaticogastrostomy, n (%) | |
| Plastic stent | 10 (90.9) |
| Metal stent | 1 (9.1) |
| Early adverse events, n (%) | 4 (36.4) |
| Biliary peritonitis | 4 (36.4) |
| Late adverse events, n (%) | 1 (9.1) |
| Biloma | 1 (9.1) |
| Exchange to 0.025-inch guidewire during procedure, n (%) | 8 (72.7) |
| Puncture from esophagus, n (%) | 0 |